CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

Overview of attention for article published in BMC Cancer, February 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 4 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 92 Mendeley
citeulike: 1 CiteULike
connotea: 2 Connotea

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

METHODS AND COMPOSITIONS FOR TREATING GLIOMA

Application WO-2022084531-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR TREATING GLIOMA

Application WO-2018029292-A1

World Intellectual Property Organisation (WIPO)

BISACODYL AND ANALOGUES AS DRUGS FOR TREATING CANCER

Application WO-2012168885-A2

World Intellectual Property Organisation (WIPO)

GLIOMA STEM CELLS AND METHODS FOR OBTAINING THEM

Application WO-2012063139-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.